Shal Jacobovitz

Shal Jacobovitz is the Chief Executive Officer of CiVi Biopharma. Mr. Jacobovitz also serves as Chairman of the Board of Clene Nanomedicine, Inc. and is a board member of Eicos Sciences, Inc., a wholly owned subsidiary of CiVi Biopharma.

Prior to joining CiVi Biopharma, Mr. Jacobovitz was the Chief Executive Officer of the American College of Cardiology. In this role, he led the 52,000+ member organization in its mission to transform cardiovascular care and improve heart health.